126 related articles for article (PubMed ID: 16507540)
1. Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.
Louden C; Brott D; Katein A; Kelly T; Gould S; Jones H; Betton G; Valetin JP; Richardson RJ
Toxicol Pathol; 2006; 34(1):19-26. PubMed ID: 16507540
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of drug-induced vascular injury.
Brott D; Gould S; Jones H; Schofield J; Prior H; Valentin JP; Bjurstrom S; Kenne K; Schuppe-Koistinen I; Katein A; Foster-Brown L; Betton G; Richardson R; Evans G; Louden C
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):441-5. PubMed ID: 15982681
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of endothelial cell activation serve as potential surrogate markers for drug-induced vascular injury.
Zhang J; Defelice AF; Hanig JP; Colatsky T
Toxicol Pathol; 2010 Oct; 38(6):856-71. PubMed ID: 20716788
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced vascular injury--a quest for biomarkers.
Kerns W; Schwartz L; Blanchard K; Burchiel S; Essayan D; Fung E; Johnson R; Lawton M; Louden C; MacGregor J; Miller F; Nagarkatti P; Robertson D; Snyder P; Thomas H; Wagner B; Ward A; Zhang J;
Toxicol Appl Pharmacol; 2005 Feb; 203(1):62-87. PubMed ID: 15694465
[No Abstract] [Full Text] [Related]
5. [Measurement of biological parameters of endothelial origin: value in human pathology].
Sampol J; George F
Ann Biol Clin (Paris); 1995; 53(6):329-38. PubMed ID: 8572378
[TBL] [Abstract][Full Text] [Related]
6. Endothelial injury in the initiation and progression of vascular disorders.
Tesfamariam B; DeFelice AF
Vascul Pharmacol; 2007 Apr; 46(4):229-37. PubMed ID: 17218160
[TBL] [Abstract][Full Text] [Related]
7. Endothelin--role in vascular disease.
Abraham D; Dashwood M
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v23-4. PubMed ID: 18784133
[TBL] [Abstract][Full Text] [Related]
8. Vascular smooth muscle and endothelial functions in aging.
Yildiz O
Ann N Y Acad Sci; 2007 Apr; 1100():353-60. PubMed ID: 17460198
[TBL] [Abstract][Full Text] [Related]
9. Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions.
Balakumar P; Kaur T; Singh M
Toxicology; 2008 Mar; 245(1-2):49-64. PubMed ID: 18242815
[TBL] [Abstract][Full Text] [Related]
10. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury.
Malabanan KP; Kanellakis P; Bobik A; Khachigian LM
Circ Res; 2008 Aug; 103(4):378-87. PubMed ID: 18617696
[TBL] [Abstract][Full Text] [Related]
11. Implications of early structural-functional changes in the endothelium for vascular disease.
Simionescu M
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):266-74. PubMed ID: 17138941
[TBL] [Abstract][Full Text] [Related]
12. Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function.
Klinkner DB; Densmore JC; Kaul S; Noll L; Lim HJ; Weihrauch D; Pritchard KA; Oldham KT; Sander TL
Shock; 2006 Jun; 25(6):575-80. PubMed ID: 16721264
[TBL] [Abstract][Full Text] [Related]
13. Bicarbonate dialysis, unlike acetate-free biofiltration, triggers mediators of inflammation and apoptosis in endothelial and smooth muscle cells.
Amore A; Cirina P; Bonaudo R; Conti G; Chiesa M; Coppo R
J Nephrol; 2006; 19(1):57-64. PubMed ID: 16523427
[TBL] [Abstract][Full Text] [Related]
14. Direct effect of dexmedetomidine on rat isolated aorta involves endothelial nitric oxide synthesis and activation of the lipoxygenase pathway.
Kim HJ; Sohn JT; Jeong YS; Cho MS; Kim HJ; Chang KC; Shin MK; Park CS; Chung YK
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):406-12. PubMed ID: 19018801
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-dependent vasoconstricting factor(s) in remodelled rat femoral arteries.
Hirao A; Kondo K; Takeuchi K; Inui N; Umemura K; Ohashi K; Watanabe H
Cardiovasc Res; 2008 Jul; 79(1):161-8. PubMed ID: 18456673
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease.
Blann AD
J Rheumatol; 1993 Sep; 20(9):1469-71. PubMed ID: 8164200
[No Abstract] [Full Text] [Related]
17. Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies.
Cai X
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):789-800. PubMed ID: 17173496
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring.
Muller PY; Dieterle F
Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1023-38. PubMed ID: 19611406
[TBL] [Abstract][Full Text] [Related]
19. Exercise induced von Willebrand Factor release -- new model for routine endothelial testing.
Balen S; Ruzić A; Mirat J; Persić V
Med Hypotheses; 2007; 69(6):1320-2. PubMed ID: 17507174
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related peptide and models of vascular disease: its expression and action in vascular smooth muscle cells.
Nishizawa Y; Koyama H; Shioi A; Hosoi M; Jono S; Hino M; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):152-6. PubMed ID: 7565439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
